本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.13
-0.0400-3.42%
盤後1.130.0001+0.01%19:53 EDT
成交量:733.66萬
成交額:809.97萬
市值:2.47億
市盈率:-0.85
高:1.20
開:1.20
低:1.06
收:1.17
資料載入中...
2021/09/20

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/15

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals